Prostate apoptosis response-4 (Par-4) is a 38-kDa protein initially identif
ied as the product of a gene upregulated in prostate tumor cells undergoing
apoptosis. Par-4 contains both a death domain and a leucine zipper domain,
and has been shown to interact with several proteins known to modulate apo
ptosis, including protein kinase C zeta, Bcl-2, and caspase-8. A rapid incr
ease in Par-4 levels occurs in neurons undergoing apoptosis in a variety of
paradigms, including trophic factor withdrawal, and exposure to oxidative
and metabolic insults. Par-4, which can be induced at the translational lev
el, acts at an early stage of the apoptotic cascade prior to caspase activa
tion and mitochondrial dysfunction. The-mechanism whereby Par-4 promotes ap
optosis may involve inhibition of the antiapoptotic transcription factor NF
-kappa B and suppression of Bcl-2 expression and/or function. Studies of po
stmortem tissues from patients and animal models of neurodegenerative disor
ders, including Alzheimer's, Parkinson's, and Huntington's diseases, amyotr
ophic lateral sclerosis (ALS), and HIV encephalitis,have documented increas
ed levels of Par-4 in vulnerable neurons. Manipulations that block Par-4 ex
pression or function prevent neuronal cell death in models of each disorder
, suggesting a critical role for Par-4 in the neurodegenerative process Int
erestingly, Par-4 levels rapidly increase in synaptic terminals following v
arious insults, and such local increases in Par-4 levels appear to play imp
ortant roles in synaptic dysfunction and degeneration. A better understandi
ng of the molecular and cellular biology of Par-4 will help clarify mechani
sms of neuronal apoptosis, and may lead to the development of novel prevent
ative and therapeutic strategies for neurodegenerative disorders.